Methotrexate-associated Lymphoproliferative Disorder Showing Colon and Liver Lesions Difficult to Distinguish from Colon Cancer with Liver Metastases: A Case Report
An 82-year-old man presented with weight loss was being treated with methotrexate (MTX) for rheumatoid arthritis. Computed tomography revealed sigmoid colonic wall thickening and multiple liver masses. Although we initially considered sigmoid colon cancer with liver metastases, the patient was diagnosed with MTX-associated lymphoproliferative disorder (MTX-LPD) based on histopathological findings and clinical course. All the lesions improved after MTX discontinuation. MTX-LPD rarely affects the gastrointestinal tract, particularly the colon. However, our case suggests that MTX-LPDs should be considered when gastrointestinal lesions are observed in patients receiving MTX.
Authors
- Masaharu Kimata
- Shumpei Unno (ORCID: https://orcid.org/0000-0001-8526-7967)
- Kensuke Kitsugi (ORCID: https://orcid.org/0009-0000-0683-2412)
- Kazuya Kanaya
- Yashiro Yoshizawa
- M. Kouda
- Kazuhiro Sugitani
- Yoshisuke Hosoda
- Kosuke Toyoda (ORCID: https://orcid.org/0000-0001-8125-4528)
- Akane Endo
- Asako Shida (ORCID: https://orcid.org/0000-0002-3667-4408)
- Yousuke Yamada
- Kouhei Mori
- Yoko Arai (ORCID: https://orcid.org/0000-0003-0602-978X)
- I. Ida
- Yousuke Kobayashi
- K. Takahashi
- Go Murohisa
Institutions
- Seirei Hamamatsu General Hospital (JP)
Publication Details
- Journal
- Internal Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2169/internalmedicine.6131-25
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00